Facebook From Breast Cancer to Rare Tumors: AKT Inhibitor Demand Outlook Driven by Precision Medicine and Biomarker Selection (2026-2032)
Logo

From Breast Cancer to Rare Tumors: AKT Inhibitor Demand Outlook Driven by Precision Medicine and Biomarker Selection (2026-2032)

クレジット
Avatar
イラストレーター
From Breast Cancer to Rare Tumors: AKT Inhibitor Demand Outlook Driven by Precision Medicine and Biomarker Selection (2026-2032)-1
シェア
Ciciの他の作品